Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Medivir AB banner

Medivir AB
LSE:0GP7

Watchlist Manager
Medivir AB Logo
Medivir AB
LSE:0GP7
Watchlist
Price: 8.05 SEK -0.12%
Market Cap: kr1.9m
Write Note Create Alert Ask AI

Wall St Price Targets

0GP7 Price Targets Summary
Medivir AB

Wall Street analysts forecast 0GP7 stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 0GP7 is 5.13 SEK with a low forecast of 3.94 SEK and a high forecast of 7.04 SEK.

0GP7 Lowest Forecast
Wall Street Target
kr3.94
-51% Downside
0GP7 Average Forecast
Wall Street Target
kr5.13
-36% Downside
0GP7 Highest Forecast
Wall Street Target
kr7.04
-13% Downside
Lowest Forecast
Price Target
3.94 SEK
51% Downside
Average Forecast
Price Target
5.13 SEK
36% Downside
Highest Forecast
Price Target
7.04 SEK
13% Downside
Medivir AB Competitors:
Price Targets
FAF
First American Financial Corp
5% Upside
CNSP
CNS Pharmaceuticals Inc
85% Upside
CIGI
Colliers International Group Inc
1% Upside
FAF
First American Financial Corp
5% Upside
CNSP
CNS Pharmaceuticals Inc
85% Upside
CIGI
Colliers International Group Inc
1% Upside

Revenue
Forecast

-83% / Year
Past Growth
11% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
-83% / Year
Past Growth
11% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 1 year, the compound annual growth rate for Revenue has been -83%. The projected CAGR for the next 2 years is 11%.

What are analyst estimates?

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Medivir AB

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Operating Income Forecast
is not available for Medivir AB

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Medivir AB

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

What are analyst estimates?

Continue 0GP7 Research

Summary
0GP7 intrinsic value, competitors valuation, and company profile.
DCF Valuation
0GP7 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
0GP7 stock valuation using valuation multiples.
Wall St Estimates
0GP7 price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
0GP7 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Medivir AB listings:
F • EUR
MVR
 XBER • EUR
MVR
 STO • SEK
MVIR B
 STO • SEK
MVIR
 F • EUR
MVR0
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 0GP7's stock price target?
Price Target
5.13 SEK

According to Wall Street analysts, the average 1-year price target for 0GP7 is 5.13 SEK with a low forecast of 3.94 SEK and a high forecast of 7.04 SEK.

What is the Revenue forecast for Medivir AB?
Projected CAGR
11%

Over the last 1 year, the compound annual growth rate for Revenue has been -83%. The projected CAGR for the next 2 years is 11%.

Back to Top
ALPHA SPREAD
Follow us
Join 355,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett